CD4+ T-CELL GENE SIGNATURE FOR RHEUMATOID ARTHRITIS (RA)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 26, 2013
app pub date -
Feb 13, 2012
filing date -
Feb 14, 2011
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to methods and products for the identification and diagnosis of Rheumatoid arthritis (RA), in particular for the diagnosis of anti-citrullinated peptide antibody (ACPA)-negative RA. Most particularly the invention relates to a gene expression signature comprising at least 12 biomarkers for use in the prognosis or diagnosis of RA.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully